CHIPPENHAM, England & HUDSON, Wis.–(BUSINESS WIRE)– #Biologics–Phillips Medisize, a Molex company and a leader in the design, development, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, today announced an investment to acquire the complete footprint of its Chippenham site. Together with its Cambridge location, the newly acquired facility strengthens the company’s Global Inhalation Center of Excellence (COE) and provides additional capacity to suppo

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.